The RGEN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the RGEN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The RGEN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View RGEN Detailed Price Forecast - CNN Money||View RGEN Detailed Summary - Google Finance|
|View RGEN Detailed Summary - Yahoo! Finance||View RGEN Stock Research & Analysis - Zacks.com|
|View RGEN Trends & Analysis - Trade-Ideas||View RGEN Major Holders - Barrons|
|View RGEN Call Transcripts - NASDAQ||View RGEN Breaking News & Analysis - Seeking Alpha|
|View RGEN Annual Report - CompanySpotlight.com||View RGEN OTC Short Report - OTCShortReport.com|
|View RGEN Fundamentals - TradeKing||View RGEN SEC Filings - Bar Chart|
|View Historical Prices for RGEN - The WSJ||View Performance/Total Return for RGEN - Morningstar|
|View the Analyst Estimates for RGEN - MarketWatch||View the Earnings History for RGEN - CNBC|
|View the RGEN Earnings - StockMarketWatch||View RGEN Buy or Sell Recommendations - MacroAxis|
|View the RGEN Bullish Patterns - American Bulls||View RGEN Short Pain Metrics - ShortPainBot.com|
|View RGEN Stock Mentions - StockTwits||View RGEN Stock Mentions - PennyStockTweets|
|View RGEN Stock Mentions - Twitter||View RGEN Investment Forum News - Investor Hub|
|View RGEN Stock Mentions - Yahoo! Message Board||View RGEN Stock Mentions - Seeking Alpha|
|View Insider Transactions for RGEN - SECform4.com||View Insider Transactions for RGEN - Insider Cow|
|View RGEN Major Holdings Summary - CNBC||View Insider Disclosure for RGEN - OTC Markets|
|View Insider Transactions for RGEN - Yahoo! Finance||View Institutional Holdings for RGEN - NASDAQ|
|View RGEN Stock Insight & Charts - FinViz.com||View RGEN Investment Charts - StockCharts.com|
|View RGEN Stock Overview & Charts - BarChart||View RGEN User Generated Charts - Trading View|
See what the IHS Markit Score report has to say about Repligen Corp.
Posted on Thursday June 28, 2018
This means that investors who seek to profit from falling equity prices are currently targeting RGEN. Over the last month, growth of ETFs holding RGEN is favorable, with net inflows of $9.18 billion. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing.
In multiple successive trials, Praesto® Jetted A50 has consistently shown significantly improved performance over today's market leading Protein A resins, due to the unique benefits of an innovative new ligand coupled to a novel jetted base matrix.
Repligen Selects Purolite Life Sciences as Commercial Partner for New High Performance Ligand
Posted on Thursday June 28, 2018
Repligen Corporation (RGEN), a life sciences company focused on bioprocessing technology leadership, today announced it has entered into an agreement with Purolite Life Sciences to supply its next-generation Protein A ligand, NGL-Impact™ A, which will be commercialized by Purolite Life Sciences using their novel Praesto® agarose jetting base bead technology. Repligen is a longtime market leader in Protein A, with two facilities that produce the majority of the global Protein A ligand demand to biopharmaceutical customers worldwide. NGL-Impact™ A was developed as part of Repligen’s collaboration with Navigo Proteins GmbH.
Repligen Announces Agreement with Navigo Proteins for the Exclusive Co-Development of Next Generation Affinity Ligands
Posted on Wednesday June 27, 2018
Repligen Corporation (RGEN), a life sciences company focused on bioprocessing technology leadership, today announced an agreement with Navigo Proteins GmbH (“Navigo”) for the advancement of exclusive novel affinity ligands used in monoclonal antibody (mAb) and non-mAb downstream purification processes. Under the terms of this agreement, Repligen and Navigo will co-develop a portfolio of next generation ligands, utilizing Navigo’s proprietary Precision Capturing™ technology platform.